Clients
At Enrich, our clients come first. Whether they're small, privately-held companies or large multi-national organizations, we're dedicated to helping them improve their businesses. Every day, our world-class products and solutions are used by companies around the world, backed by our outstanding customer support.
Case Studies:
- Using the Enrich Portfolio System for Strategic Financial Management
- Cross-Functional Portfolio Planning
- Market Analysis and Portfolio Management
Using the Enrich Portfolio System for Strategic Financial Management
A large producer of medical devices was having difficultly using its strategic planning process to make sound decisions about existing products and R&D initiatives. The results of the process fell short of expectations each year, as there was little consistency across assessments of different projects, and little transparency into the key assumptions and drivers of project value. In addition, the process was extremely cumbersome, requiring extensive effort by many personnel across the organization.Enrich worked with a cross-functional group of key individuals within the organization to develop a streamlined process that addressed the specific needs of each business area. Enrich also created a customized set of valuation templates within its Enrich Portfolio System (EPS) to provide an analytic backbone for the process. The EPS was then used to:
- Ensure consistency of analytic methods across projects
- Provide transparency into critical data and assumptions
- Enhance communication of key information through a web-based framework
- Enable seamless integration of project assessments and alternative scenarios into portfolio views
- Faciliate rapid decision-making by providing concise, real-time summaries of key metrics
The new process, combined with the EPS, enabled the organization to make more informed decisions about its existing products and R&D initiatives, and respond to changing markets and technologies much more rapidly. Furthermore, the results from the process were leveraged to inform other decision-making processes across the broader organization.
Cross-Functional Portfolio Planning
A large producer of medical devices was having difficultly using its strategic planning process to make sound decisions about existing products and R&D initiatives. The results of the process fell short of expectations each year, as there was little consistency across assessments of different projects, and little transparency into the key assumptions and drivers of project value. In addition, the process was extremely cumbersome, requiring extensive effort by many personnel across the organization.Enrich worked with a cross-functional group of key individuals within the organization to develop a streamlined process that addressed the specific needs of each business area. Enrich also created a customized set of valuation templates within its Enrich Portfolio System (EPS) to provide an analytic backbone for the process. The EPS was then used to:
- Ensure consistency of analytic methods across projects
- Provide transparency into critical data and assumptions
- Enhance communication of key information through a web-based framework
- Enable seamless integration of project assessments and alternative scenarios into portfolio views
- Faciliate rapid decision-making by providing concise, real-time summaries of key metrics
The new process, combined with the EPS, enabled the organization to make more informed decisions about its existing products and R&D initiatives, and respond to changing markets and technologies much more rapidly. Furthermore, the results from the process were leveraged to inform other decision-making processes across the broader organization.
Market Analysis and Portfolio Management
A medical device manufacturer had a large number (30+) of new and existing products in several related therapeutic areas. With multiple products in some markets, and some products spanning multiple markets, it was a challenge to forecast revenues for any one product and to accurately identify gaps in the firm’s product line.Working with the firm’s strategic marketing group, Enrich developed a framework for consideration of the market within each therapeutic area. It incorporated market evolution across multiple therapies and disease states over time, as well consideration of “market maker” behavior, where the introduction of breakthrough products would change the size of some markets.
In order to forecast revenues, Enrich built analytics to anticipate competitors’ market entry and to determine market share in the face of competition. Recognizing that new product introduction could lead to cannibalization of existing product revenues, these analytics also captured the interaction between products when, and if, they reached the market. With the development, marketing, and finance groups' involvement, these forecasting models were incorporated into an Enrich Portfolio System (EPS) to allow management to review and evaluate the company-wide portfolio of new and existing products.
EPS enables instant access to detailed market and project analyses, so that executives immediately understand the companies' competitive position, accurately value each product in the pipeline, and identify future market and product opportunities.
Some of our Clients
